Results 91 to 100 of about 1,141,071 (189)

Effectiveness and safety of repeated photodynamic therapy in recurrent central serous chorioretinopathy

open access: yesActa Ophthalmologica, Volume 103, Issue 7, Page 791-798, November 2025.
Abstract Purpose To evaluate anatomical and functional outcomes after a second photodynamic therapy (PDT) in patients with central serous chorioretinopathy (CSC), who had a recurrence of subretinal fluid (SRF) after a previously successful PDT. Methods In this multicentre retrospective cohort study, we included patients with CSC who underwent a second ...
F. M. van den Tillaart   +4 more
wiley   +1 more source

Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

open access: yesBMC Ophthalmology, 2020
Background To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizumab alone.
Olga Furashova   +3 more
doaj   +1 more source

Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema

open access: yes, 2014
Ihab Saad Othman,1 Sherif Ahmed Eissa,1 Mohamed S Kotb,1 Sherin Hassan Sadek21Cairo University, Cairo, 2Fayoum University, Al Fayoum, EgyptBackground: The purpose of this study was to evaluate subthreshold diode-laser micropulse (SDM) photocoagulation as
Kotb MS, Sadek SH, Othman IS, Eissa SA
core  

Micropulse diode laser versus bevacizumab in chronic central serous chorioretinopathy: a pilot study

open access: yes, 2017
<p class="abstract"><strong>Background:</strong> Central serous chorioretinopathy (CSC) is an idiopathic condition with an illdefined aetiopathogenesis and no clearly effective treatment.
Ashutosh Gupta   +2 more
core   +1 more source

Our first experience with subtreshold diode laser in the treatment of macular edema

open access: yesZdravniški Vestnik, 2012
Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium.
Davorin Sevšek   +2 more
doaj  

Micropulse laser therapy in chronic idiopathic central serous chorioretinopathy in right eye of 38-year-old patient – case report

open access: yesAnnales Academiae Medicae Silesiensis
INTRODUCTION: Central serous chorioretinopathy (CSC) is a disease characterized by idiopathic serous elevation of the sensory layer of the retina in the proximity of the macula.
Maciej Michalik   +3 more
doaj   +1 more source

Comparison of Continuous-Wave and Micropulse Modulation in Retinal Laser Therapy

open access: yesInvestigative Opthalmology & Visual Science, 2017
Recent progress in retinal laser therapy has centered upon using thermal stress below damage threshold or selective destruction of targeted tissue layers as a stimulus for retinal repair. Temporal modulation, including micropulse, is thought to increase the selectivity of laser treatment, but has not been carefully analyzed.
Jenny, Wang   +3 more
openaire   +2 more sources

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

open access: yesTrials, 2019
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Noemi Lois   +27 more
doaj   +1 more source

Micropulse Laser for Persistent Sub-Retinal Fluid in a Patient Previously Treated for Rhegmatogenous Retinal Detachment [PDF]

open access: yes, 2018
The purpose of this study was to report the resolution of persistent Sub-Retinal Fluid (SRF) induced by subthreshold micropulse laser treatment in a patient, formerly treated for rhegmatogenous retinal detachment by retinal pneumopexy.
Landa, Gennady
core   +2 more sources

CHANGES OF AQUEOUS HUMOR MÜLLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT

open access: yes, 2020
PURPOSE: To evaluate the changes in activity of biomarkers of Mu[Combining Diaeresis]ller cells (MC) in aqueous humor of patients with diabetic macular edema after subthreshold micropulse laser, over 1 year.
Midena E   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy